lymecycline

North America

Canada (0)
No result.
United States (0)
No result.

Europe

Austria (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CYCLOPEL 300 MG caps
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CYCLOPEL 300 MG caps
136100
30-03-2015
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLINE KINEDEXE 408 MG caps, hard
28x
56x
-
-

oral
J01AA04
TETRALYSAL 300 MG caps, hard
16x
28x
56x
-
Y
Y


oral
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLINE KINEDEXE 408 MG caps, hard
28x
56x
BE437236
BE437236
-
-
TETRALYSAL 300 MG caps, hard
16x
28x
56x
BE016037
BE016037
BE016037
-
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
LYMECYCLINE KINEDEXE 408 MG caps, hard
28x
56x
TETRALYSAL 300 MG caps, hard
16x
28x
56x
10,96
17,51
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLIN ACTAVIS 300 MG caps, hard
-
-
J01AA04
LYMECYCLIN KINEDEXE 300 MG caps, hard
-
-
J01AA04
LYMECYCLIN ORIFARM 300 MG caps, hard
-
-
J01AA04
LYMELYSAL 300 MG caps, hard
-
-
J01AA04
TETRALYSAL 150 MG caps, hard
-
-
J01AA04
TETRALYSAL 150 MG caps, hard
-
-
J01AA04
TETRALYSAL 300 MG caps, hard
-
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLIN ACTAVIS 300 MG caps, hard
28105015211
DCP
16-01-2013
LYMECYCLIN KINEDEXE 300 MG caps, hard
28104901111
DCP
20-09-2012
LYMECYCLIN ORIFARM 300 MG caps, hard
28105787316
PI
01-07-2016
LYMELYSAL 300 MG caps, hard
28105686815
DCP
09-12-2016
TETRALYSAL 150 MG caps, hard
28100396662
NP
29-05-1962
TETRALYSAL 150 MG caps, hard
28105916017
PI
14-06-2017
TETRALYSAL 300 MG caps, hard
28100552969
NP
29-04-1969
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
LYMECYCLIN ACTAVIS 300 MG caps, hard
LYMECYCLIN KINEDEXE 300 MG caps, hard
LYMECYCLIN ORIFARM 300 MG caps, hard
LYMELYSAL 300 MG caps, hard
TETRALYSAL 150 MG caps, hard
TETRALYSAL 150 MG caps, hard
TETRALYSAL 300 MG caps, hard
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLINE KINEDEXE 300 MG caps, hard
28x in blister
56x in blister
N
N
Rx
Rx
-
J01AA04
LYMECYCLINE RATIOPHARM 300 MG caps, hard
100x in blister
16x in blister
20x in blister
21x in blister
28x in blister
56x in blister
Y
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
Rx
-
J01AA04
TETRALYSAL 150 MG caps, hard
100x in strip
N
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
100x in strip
20x in strip
Y
N
Rx
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLINE KINEDEXE 300 MG caps, hard
28x in blister
56x in blister
29884
29884
-
-
07-03-2013
07-03-2013
LYMECYCLINE RATIOPHARM 300 MG caps, hard
100x in blister
16x in blister
20x in blister
21x in blister
28x in blister
56x in blister
30471
30471
30471
30471
30471
30471
-
-
-
-
-
-
21-12-2012
21-12-2012
21-12-2012
21-12-2012
21-12-2012
21-12-2012
TETRALYSAL 150 MG caps, hard
100x in strip
3784
-
27-07-1966
TETRALYSAL 300 MG caps, hard
100x in strip
20x in strip
5752
5752
-
-
30-04-1969
30-04-1969
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
SEBLYN 408 MG caps, hard
28x blister
56x blister
N
N
Rx
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16x szalagcsomagolásban
28x szalagcsomagolásban
N
Y
Rx
Rx
oral
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
SEBLYN 408 MG caps, hard
28x blister
56x blister
OGYI-T-22875/01
OGYI-T-22875/02
22-07-2015
22-07-2015
TETRALYSAL 300 MG caps, hard
16x szalagcsomagolásban
28x szalagcsomagolásban
OGYI-T-09555/01
OGYI-T-09555/02
27-04-2004
27-04-2004
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
SEBLYN 408 MG caps, hard
28x blister
56x blister
0
0
0
0
0
0
0
0
TETRALYSAL 300 MG caps, hard
16x szalagcsomagolásban
28x szalagcsomagolásban
0
0
0
0
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLINE ACTAVIS 300 MG caps, hard
Y
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLINE ACTAVIS 300 MG caps, hard
28-11-2014
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
LYMECYCLINE ACTAVIS 300 MG caps, hard
3.333
3.333
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYCIMOR 300 MG HARD caps, hard
Y
Rx
oral
J01AA04
RIMICORIM 300MG 300 MG caps
N
Rx
oral
J01AA04
TETRALYSAL 300 MG caps, hard
-
Rx
oral
J01AA04
TETRALYSAL 300 MG caps, hard
-
Rx
oral
J01AA04
TETRALYSAL 300 MG HARD caps, hard
-
Rx
oral
J01AA04
TETRALYSAL 300 MG HARD 300 BASE MGS caps, hard
-
Rx
oral
J01AA04
TETRALYSAL 300MG HARD 300 MG caps, hard
Y
Rx
oral
J01AA04
TETRALYSAL 300MG HARD 300 MG caps, hard
-
Rx
oral
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYCIMOR 300 MG HARD caps, hard
PA1380/130/001
15-02-2013
RIMICORIM 300MG 300 MG caps
PA23148/001/001
05-04-2013
TETRALYSAL 300 MG caps, hard
PPA1463/080/001
04-07-2013
TETRALYSAL 300 MG caps, hard
DPR1633/020/001
TETRALYSAL 300 MG HARD caps, hard
PPA1463/133/001
18-04-2013
TETRALYSAL 300 MG HARD 300 BASE MGS caps, hard
PPA0465/256/001
01-10-2010
TETRALYSAL 300MG HARD 300 MG caps, hard
PA22743/016/001
26-02-1982
TETRALYSAL 300MG HARD 300 MG caps, hard
PPA1633/029/001
05-07-2013
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (0)
No result.
Malta (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TETRALYSAL 300MG caps
Rx
-
J01AA04
TETRALYSAL 300MG caps, hard
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TETRALYSAL 300MG caps
AA117/00703
13-06-2019
TETRALYSAL 300MG caps, hard
AA117/00702
31-01-2008
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (0)
No result.
Norway (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLIN ACTAVIS 300 MG caps, hard
100
21
-
-
Rx
Rx
oral
J01AA04
TETRALYSAL 300 MG caps, hard
100
-
Rx
oral
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLIN ACTAVIS 300 MG caps, hard
100
21
01-05-2013
01-05-2013
TETRALYSAL 300 MG caps, hard
100
01-01-2001
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DAMELIUM 408 MG caps, hard
16 caps
28 caps
56 caps
-
-
-
Rx
Rx
Rx
-
J01AA04
DAMELIUM 408 MG caps, hard
14 caps
28 caps
-
-
Rx
Rx
-
J01AA04
DAMELIUM 408 MG caps, hard
14 caps
28 caps
28 caps
56 caps
56 caps
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
-
J01AA04
DAMELIUM 408 MG caps, hard
14 caps
28 caps
-
-
Rx
Rx
-
J01AA04
TETRALYSAL 150 MG caps, hard
16 caps
-
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
-
-
Rx
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
-
-
Rx
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
-
-
Rx
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
-
-
Rx
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
-
-
Rx
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DAMELIUM 408 MG caps, hard
16 caps
28 caps
56 caps
20960
20960
20960
DCP
DCP
DCP
05-06-2019
05-06-2019
05-06-2019
DAMELIUM 408 MG caps, hard
14 caps
28 caps
440/16
440/16
PI
PI
05-06-2020
05-06-2020
DAMELIUM 408 MG caps, hard
14 caps
28 caps
28 caps
56 caps
56 caps
264/15
362/15
264/15
362/15
264/15
PI
PI
PI
PI
PI
24-05-2020
05-06-2020
24-05-2020
05-06-2020
24-05-2020
DAMELIUM 408 MG caps, hard
14 caps
28 caps
180/16
180/16
PI
PI
05-06-2020
05-06-2020
TETRALYSAL 150 MG caps, hard
16 caps
09640
NP
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
146/10
146/10
PI
PI
28-09-2025
28-09-2025
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
371/14
371/14
PI
PI
17-11-2019
17-11-2019
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
12736
12736
NP
NP
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
26/14
26/14
PI
PI
21-01-2019
21-01-2019
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
44/15
44/15
PI
PI
27-01-2025
27-01-2025
Product
Pack
SPC
PIL
Company
DAMELIUM 408 MG caps, hard
16 caps
28 caps
56 caps
DAMELIUM 408 MG caps, hard
14 caps
28 caps
DAMELIUM 408 MG caps, hard
14 caps
28 caps
28 caps
56 caps
56 caps
DAMELIUM 408 MG caps, hard
14 caps
28 caps
TETRALYSAL 150 MG caps, hard
16 caps
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
TETRALYSAL 300 MG caps, hard
16 caps
28 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LYMECYCLIN ORIFARM 300 MG caps, hard
Rx
-
J01AA04
LYMECYCLINE ACTAVIS 300 MG caps, hard
Rx
-
J01AA04
LYMECYKLIN BROWN & BURK (FD LYMECYKLIN NRIM) 300 MG caps, hard
Rx
-
J01AA04
LYMELYSAL 300 MG caps, hard
Rx
-
J01AA04
TETRALYSAL 150 MG caps, hard
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
Rx
-
J01AA04
TETRALYSAL 300 MG caps, hard
Rx
Rx
Rx
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LYMECYCLIN ORIFARM 300 MG caps, hard
PI
15-02-2017
31-12-2019
LYMECYCLINE ACTAVIS 300 MG caps, hard
Nationell decentral eller ömsesidig
14-12-2012
LYMECYKLIN BROWN & BURK (FD LYMECYKLIN NRIM) 300 MG caps, hard
Nationell decentral eller ömsesidig
06-12-2012
LYMELYSAL 300 MG caps, hard
Nationell decentral eller ömsesidig
08-11-2016
TETRALYSAL 150 MG caps, hard
Nationell decentral eller ömsesidig
17-02-1964
TETRALYSAL 300 MG caps, hard
Nationell decentral eller ömsesidig
29-08-1969
TETRALYSAL 300 MG caps, hard
PI
PI
PI
13-11-2003
12-02-2003
20-09-2002
31-08-2008
31-08-2008
31-08-2008
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TETRALYSAL 300 MG caps
-
A
-
J01AA04
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TETRALYSAL 300 MG caps
56853 1
Hauptzulassung
12-08-2005
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.